Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-06-03FDA Approved: THEOPHYLLINE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's Theophylline as a new original ANDA, enabling a generic Theophylline product. Theophylline is a bronchodilator used …
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: The Effect of Inhaled PUL-042 on Rhinovirus-induced Symptoms in Smokers With GOLD Stage 0 COPD [Phase 2]
Phase 2 clinical trial evaluating inhaled PUL-042 for rhinovirus-induced symptoms in smokers with COPD (GOLD stage 0) has completed.
-
FDA approval · 2021-06-01FDA Approved: ALBUTEROL SULFATE — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s original application for albuterol sulfate. This approval makes a generic albuterol sulfat…
-
CLINICAL_TRIALS trial_result · 2021-05-26Clinical Trial Update: Evaluation of a Portable Oxygen Concentrator During Ambulation for Patients Who Require Supplemental Oxygen (POC-LEAN) [NA]
A completed clinical trial evaluating a portable oxygen concentrator for ambulation in COPD patients; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD [Phase 2, Phase 3]
A phase 2/3 trial assessing combination antibiotic therapy versus monotherapy for acute COPD exacerbation has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease [Phase 2]
A Phase 2 trial evaluating tiotropium bromide inhalation solution in subjects with chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Study Evaluating 5 Doses of RPL554 and Placebo in COPD Patients Via a Dry Powder Inhaler [Phase 2]
A Phase 2 study evaluating five doses of RPL554 versus placebo in COPD patients via a dry powder inhaler has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 Agonists
A completed clinical trial comparing cardiovascular events in COPD patients initiating olodaterol versus other long-acting beta2 agonists, w…
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: To Investigate the Efficacy and Safety of OPC-6535 in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]
Phase 2 clinical trial on OPC-6535 for COPD has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Prednisone Administration in Quiescent COPD Patients to Determine the Effect on Gene Expression [Phase 4]
Phase 4 trial evaluating prednisone administration in quiescent COPD patients to assess changes in gene expression.
-
CLINICAL_TRIALS trial_result · 2021-04-27Clinical Trial Update: An Observational Outcomes Study for Autologous Cell Therapy Among Patients With COPD and Interstitial Lung Disease
An observational outcomes study of autologous cell therapy in patients with COPD and interstitial lung disease has completed, with results p…
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Evaluating the Outcome of Cardio Selective beta1- Blockers Use in Patients With Copd [Phase 4]
Phase 4 trial update evaluating cardioselective beta1-blockers in patients with COPD.
-
CLINICAL_TRIALS trial_result · 2021-04-12Clinical Trial Update: Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]
Phase 2 trial update on a fixed triple therapy inhaler (beclomethasone dipropionate + formoterol fumarate + glycopyrronium bromide) for COPD…
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: A Clinical Study to Investigate if a Single Dose of an Approved Drug Product (Glycopyrrolate Inhalation Solution) Reduces Trapped Air in the Lungs of Participants With Chronic Obstructive Pulmonary Disease. [Phase 4]
Phase 4 clinical trial evaluating whether a single dose of glycopyrrolate inhalation solution reduces trapped air in COPD patients; trial co…
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Vector Engineering Clinical [NA]
A completed clinical trial update for vector engineering conducted by Philips in COPD patients; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-05Clinical Trial Update: Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness [Phase 3]
Phase 3 bioequivalence study comparing test and reference inhalation products in COPD patients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-02Clinical Trial Update: Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery [Phase 3]
Phase 3 trial evaluating perioperative bronchodilator use in COPD patients undergoing lung cancer surgery; status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD) [Phase 3]
Phase 3 trial comparing CHF5993 pMDI to Symbicort Turbuhaler in COPD completed.
-
FDA approval · 2021-03-31FDA Approved: BUDESONIDE INHALATION — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Budesonide Inhalation by Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: RESP-FIT: Technology-Enhanced Self-Management in COPD [NA]
Clinical trial update for RESP-FIT, a technology-enhanced self-management program in COPD, with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: The Role of Ambulatory Oxygen in Improving the Effectiveness of Pulmonary Rehabilitation for COPD Patients [NA]
A terminated clinical trial on ambulatory oxygen and pulmonary rehabilitation in COPD patients with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Effects of Liraglutide in Chronic Obstructive Pulmonary Disease [Phase 4]
Clinical trial update for liraglutide in chronic obstructive pulmonary disease (Phase 4) completed.
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease [Phase 2]
Phase 2 trial evaluating tadalafil for pulmonary hypertension due to chronic lung disease (COPD) has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: Targeted Retreatment of COPD Exacerbations [Phase 3]
A Phase 3 clinical trial investigating targeted retreatment of COPD exacerbations has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: NBMI - Clinical Study on COPD [Phase 2]
Phase 2 clinical trial update for NBMI in chronic obstructive pulmonary disease and COPD bronchitis has completed.